Meeting abstract

https://doi.org/10.15836/ccar2019.88

Secondary mitral regurgitation – when surgery "may be considered"

Siniša Roginić orcid.org/0000-0002-0384-8088 ; Zabok General Hospital, Zabok, Croatia; Clinic for Cardiovascular Diseases Magdalena, Krapinske Toplice, Croatia
Jelena Zajec Gorički ; Zabok General Hospital, Zabok, Croatia
Marija Čajko ; Zabok General Hospital, Zabok, Croatia
Krešimir Štambuk ; Clinic for Cardiovascular Diseases Magdalena, Krapinske Toplice, Croatia

Abstract

Introduction: Secondary mitral regurgitation (MR) is a dynamic myocardial disease accompanying cardiomyopathy and coronary artery disease.1-4
Case report: We present a case of 63-year-old patient with long standing cardiomyopathy after breast cancer chemotherapy. Her left ventricle (LV) is slightly dilated with moderately impaired systolic function (estimated EF 30%) and severe diastolic disfunction. Significant MR (Figure 1, Figure 2) has been present for years but patient’s condition deteriorated rapidly with frequent admissions for heart failure despite optimal medical therapy. Upon last discharge echocardiography showed slight improvement in LV systolic function and persistent severe secondary MR. She has no significant coronary artery
disease or indication for CRT. Discussion and Conclusion: Severe secondary MR is in most cases treated conservatively, especially
in the absence of other surgical indication. According to guidelines mitral valve intervention (surgery or transcatheter procedure) may be considered in refractory cases after heart team discussion. Our patient was subsequently scheduled for mitral valve replacement.

Keywords

mitral regurgitation; cardiomyopathy; mitral valve surgery

Hrčak ID:

220629

URI

https://hrcak.srce.hr/220629

Publication date:

31.5.2019.

Visits: 1.171 *